News | March 06, 2024
Bayer aims to enhance performance and regain strategic flexibility by 2026
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
Launch of Indian public health standards for Ayush healthcare facilities
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy
The CDCCs are strategically positioned in regions identified as high-impact areas
_256_384.png){kind=logo}
4 FDA clearances & 61 EU MDR CE tags achieved for AI in 18 months
1,000 Ph.D. students will be enrolled in the next five years to drive innovation in the critical healthcare sector
Delivers keynote address at the 4th convocation of AIIMS Jodhpur
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
